GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Athena Technology Acquisition Corp II (AMEX:ATEK) » Definitions » Cash And Cash Equivalents

Athena Technology Acquisition II (Athena Technology Acquisition II) Cash And Cash Equivalents : $0.03 Mil (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Athena Technology Acquisition II Cash And Cash Equivalents?

Athena Technology Acquisition II's quarterly cash and cash equivalents declined from Mar. 2023 ($0.31 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Sep. 2023 ($0.03 Mil).

Athena Technology Acquisition II's annual cash and cash equivalents increased from . 20 ($0.00 Mil) to Dec. 2021 ($1.53 Mil) but then declined from Dec. 2021 ($1.53 Mil) to Dec. 2022 ($0.42 Mil).

Athena Technology Acquisition II Cash And Cash Equivalents Historical Data

The historical data trend for Athena Technology Acquisition II's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Athena Technology Acquisition II Cash And Cash Equivalents Chart

Athena Technology Acquisition II Annual Data
Trend Dec21 Dec22
Cash And Cash Equivalents
1.53 0.42

Athena Technology Acquisition II Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only 0.52 0.42 0.31 - 0.03

Athena Technology Acquisition II Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Athena Technology Acquisition II  (AMEX:ATEK) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Athena Technology Acquisition II Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Athena Technology Acquisition II's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Athena Technology Acquisition II (Athena Technology Acquisition II) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Athena Technology Acquisition Corp II (AMEX:ATEK) » Definitions » Cash And Cash Equivalents
Comparable Companies
VMCA ACAH DHCA ZLS BMAC LGVC GPAC FIAC IRRX CSTA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA
Traded in Other Exchanges
N/A
Address
442 5th Avenue, New York, NY, USA, 10018
Website
https://www.athenaspac.com
Athena Technology Acquisition Corp II is a blank check company.
Executives
Trier Bryant director 2220 WESTCREEK LN 1404, HOUSTON TX 77027
Judith Rodin director C/O UNIVERSITY OF PENNSYLVANIA, 100 COLLEGE HALL, PHILADELPHIA PA 19104-6380
Sharon Brown-hruska director C/O MARKETAXESS HOLDINGS INC., 299 PARK AVENUE, NEW YORK NY 10171
Randi Zuckerberg director 394 PACIFIC AVE., SUITE 2, SAN FRANCISCO CA 94111
Kirthiga Reddy officer: President C/O PEAR THERAPEUTICS, INC., 200 STATE STREET, 13TH FLOOR, BOSTON MA 02109
Isabelle D. Freidheim director, 10 percent owner, officer: Chief Executive Officer 125 TOWNPARK DRIVE, SUITE 300, KENNESAW GA 30144
Athena Technology Sponsor Ii, Llc 10 percent owner 442 5TH AVENUE, NEW YORK NY 10018
Anna Apostolova officer: Chief Financial Officer C/O ATHENA TECHNOLOGY ACQUISITION CORP., 442 5TH AVENUE, NEW YORK NY 10018